From SEDAR:
2319634.2
Form 51–102F3
Material Change Report
Item 1 Name and Address of Company
Tekmira Pharmaceuticals Corporation
200 - 8900 Glenlyon Parkway
Glenlyon Business Park
Burnaby, B.C.
V5J 5J8
(“Tekmira”)
Item 2 Date of Material Change
May 30, 2008
Item 3 News Release
A press release was issued by Tekmira through Marketwire on June 2, 2008.
Item 4 Summary of Material Change
Tekmira Pharmaceuticals Corporation (“Tekmira”) announced on June 2, 2008 that it had completed the business combination (the “Business Combination”) with Protiva Biotherapeutics
Inc. (“Protiva”).
FEATURED Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • Oct 1, 2024 8:30 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM
BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM